Abeona Therapeutics holds annual meeting; elects three Class 3 directors

ABEONA THERAPEUTICS INC.

Mark J. Alvino, Faith L. Charles, and Donald A. Wuchterl elected as Class 3 directors.
Alvino received 26,260,868 votes for, Charles 26,774,705, Wuchterl 26,856,990.
Advisory vote on NEO compensation approved: 25,777,223 for, 1,552,881 against.
Ratification of Deloitte & Touche as auditor for FY 2025 approved: 34,334,516 for.
All proposals passed with broker non-votes on director election and say-on-pay.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.